Kathryn H. Ching

Kathryn H. Ching's work experience includes positions at several companies. Kathryn H. is currently a Senior Scientist at NextVivo, starting their role in September 2021. Prior to that, they worked at Ligand Pharmaceuticals, where they held the positions of Research Investigator from October 2019 to October 2021, and Senior Scientist from October 2017 to October 2019. Before Ligand Pharmaceuticals, they were a Senior Scientist at Crystal Bioscience from August 2013 to October 2017. Their career also includes a role as a Research Biologist at USDA from July 2011 to August 2013, and as a Postdoctoral Fellow at the National Institutes of Health from September 2008 to June 2011.

Kathryn H. Ching completed their education with a Ph.D. in Biochemistry and Molecular Biology from Georgetown University, where they studied from 2001 to 2006. Prior to their doctoral studies, they earned a Bachelor of Science degree in Biochemistry from Seattle University, completing their undergraduate education from 1997 to 2001. While their high school education is not provided, it is known that they attended San Francisco University High School. Additionally, they also attended The Hamlin School, although the specific duration and field of study for both high schools are not specified.